How Phillips-Medisize helped Sotech Health develop a breath analyzer for COVID-19

Sotech Health and Phillips-Medisize claim the breath analyzer can detect traces of the virus that causes COVID-19 within 30 seconds. [Image courtesy of Phillips-Medisize and Sotech Health]Medtech contract manufacturing giant Phillips-Medisize used its human-factors product design expertise to help startup Sotech Health create what the companies claim is a breath sensor system that can detect COVID-19 in less than 30 seconds.

Dallas-based Sotech Health has submitted the device to the FDA for an emergency use authorization. It’s also seeking regulatory nods in Canada, the United Kingdom and the European Union.

Phillips-Medisize (Hudson, Wisconsin) is readying its global production facilities to keep pace with the anticipated demand for the Sotech Health breath analyzer. A Molex company, Phillips-Medisize has 36 facilities worldwide.

Get the full story on our sister site Medical Design & Outsourcing. 

Read more
  • 0

How Phillips-Medisize helped Sotech Health develop a breath analyzer for COVID-19

Sotech Health and Phillips-Medisize claim the breath analyzer can detect traces of the virus that causes COVID-19 within 30 seconds. [Image courtesy of Phillips-Medisize and Sotech Health]

Medtech contract manufacturing giant Phillips-Medisize used its human-factors product design expertise to help startup Sotech Health create what the companies claim is a breath sensor system that can detect COVID-19 in less than 30 seconds.

Dallas-based Sotech Health has submitted the device to the FDA for an emergency use authorization. It’s also seeking regulatory nods in Canada, the United Kingdom and the European Union.

Phillips-Medisize (Hudson, Wisconsin) is readying its global production facilities to keep pace with the anticipated demand for the Sotech Health breath analyzer. A Molex company, Phillips-Medisize has 36 facilities worldwide.

The contract manufacturer boasts that its electronics, produ…

Read more
  • 0

Phillips-Medisize, Exact Sciences to collaborate on colorectal cancer screening

Phillips-Medisize and Exact Sciences (NSDQ:EXAS) today announced a collaboration to advance early cancer detection.

The collaboration centers around Exact Sciences’ Cologuard, the first and only FDA-approved, non-invasive stool DNA screening test for colorectal cancer, according to a news release.

Phillips-Medisize, a Molex company, said the collaboration will seek to focus on the patient experience through the simplicity and convenience of at-home testing. The company developed new tooling to safeguard against inadvertent leaks while meeting specifications and tolerances required to produce the highest levels of product quality.

Exact Sciences was able to utilize supply chain flexibility to acquire all components needed to rapidly scale production of the kit, while Phillips-Medisize located and validated alternate supply sources, conducted risk assessments and forecasting and created sourcing and procurement plans to protect against unplanned disr…

Read more
  • 0

Phillips-Medisize expands its global manufacturing capacity

Phillips-Medisize announced today that it expanded its global manufacturing capacity through a number of collaborations and internal initiatives.

Hudson, Wisconsin-based Phillips-Medisize, a Molex company, said its global reach now encompasses 36 world-class facilities with scalable, end-to-end capabilities tailored to help customers bring products to market quickly and efficiently from anywhere in the world.

Get the full story at our sister site, Medical Design & Outsourcing.

Read more
  • 0

Phillips-Medisize expands its global manufacturing capacity

Phillips-Medisize announced today that it expanded its global manufacturing capacity through a number of collaborations and internal initiatives.

Hudson, Wisconsin-based Phillips-Medisize, a Molex company, said its global reach now encompasses 36 world-class facilities with scalable, end-to-end capabilities tailored to help customers bring products to market quickly and efficiently from anywhere in the world.

“As the preferred partner for leading global customers, we continually invest in new talent and technologies that increase the capacity and capabilities of Phillips-Medisize across the entire value chain,” Molex president of medical & pharmaceutical solutions Paul Chaffin said in a news release. “Our expanded global reach and resources will enable us to solve complex development and manufacturing challenges while meeting escalating customer demands for more localized production, supply chain management and accelerated go-to-market strategies.”

P…

Read more
  • 0

Phillips-Medisize unveils Aria smart autoinjector

Phillips-Medisize Aria Smart Autoinjector platform featuring a reusable electronic drive unit and single-use, disposable cassettes [Image from Phillips-Medisize]

Phillips-Medisize today unveiled the Aria smart autoinjector platform designed to elevate patient care and reduce environmental impact.

Hudson, Wis.-based Phillips-Medisize, a Molex company, said in a news release that the Aria platform introduces a small, simple smart injection device with a reusable electronic drive unit and single-use, disposable cassettes.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0

Phillips-Medisize unveils Aria smart autoinjector

Phillips-Medisize Aria Smart Autoinjector platform featuring a reusable electronic drive unit and single-use, disposable cassettes [Image from Phillips-Medisize]Phillips-Medisize today unveiled the Aria smart autoinjector platform designed to elevate patient care and reduce environmental impact.

Hudson, Wis.-based Phillips-Medisize, a Molex company, said in a news release that the Aria platform introduces a small, simple smart injection device with a reusable electronic drive unit and single-use, disposable cassettes.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0

Most pharma executives see digital drug delivery as important, Molex says

A survey conducted by Molex and its Phillips-Medisize medical device delivery division highlights the importance of digitized drug delivery.

Lisle, Ill.-based Molex and Phillips-Medisize commissioned Dimensional Research to poll 215 qualified pharmaceutical professionals who are all stakeholders in a range of digital drug delivery devices, according to a news release.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0

Most pharma executives see digital drug delivery as important, Molex says

A survey conducted by Molex and its Phillips-Medisize medical device delivery division highlights the importance of digitized drug delivery.

Lisle, Ill.-based Molex and Phillips-Medisize commissioned Dimensional Research to poll 215 qualified pharmaceutical professionals who are all stakeholders in a range of digital drug delivery devices, according to a news release.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0

Phillips-Medisize, Subcuject team on wearable osmotic bolus injector

Phillips-Medisize announced today that it is collaborating with Subcuject to bring a wearable bolus injector to market.

Hudson, Wis.-based Phillips-Medisize, a Molex company, said in a news release that the on-body delivery system technology that is based on osmosis is now available for the next stage of drug-specific wearable injector solution after Subcuject filed for intellectual property of the concept.

The wearable osmotic bolus injector is designed as a low-cost, patient-friendly, pre-filled wearable injector for single use. It uses osmosis to generate the force to complete a full injection cycle and requires no additional electronics or batteries.

Phillips-Medisize and Subcuject said they are exploring the opportunity to meet the demand for larger-volume drug delivery, allowing patients to self-administer certain medications almost anywhere instead of relying upon healthcare professionals to do so in a clinical setting.

“We are very p…

Read more
  • 0

Molex taps former Ecolab SVP to run its medical business, including Phillips-Medisize

Paul Chaffin, SVP of Molex’s Medical and Pharmaceutical Solutions division

Paul Chaffin — most recently SVP of enterprise initiatives at Ecolab — has become SVP in charge of Molex’s Medical and Pharmaceutical Solutions division, including contract manufacturing giant Phillips-Medisize.

Chaffin will report to Molex CEO Joe Nelligan and will be a member of the company’s Global Leadership Team.

“Paul’s depth of healthcare, commercial and international experience combined with his strong leadership skills will be a big asset to not only our medical business but to the Molex leadership team.  We’re confident that Paul will help fulfill our vision of expanding our global footprint with innovative and digitally connected medical solutions at a time when delivering top-quality care to patients around the world is so critical,” said Joe Nelligan, CEO of Molex.

Chaffin described the combined…

Read more
  • 0